1050218-85-3

Upstream product

• 1050509-52-8 2,3,4-tri-O-benzyl-5a-carba-α-D-fucopyranose 
• 800407-54-9 (S)-3-Benzyl-4-((4S,5R)-2,2-dimethyl-5-tetradecyl-[1,3]dioxolan-4-yl)-[1,2,3]oxathiazolidine 2,2-dioxide 

Downstream Products

• 1050218-89-7 (2S,3S,4R)-1-O-(2,3,4-tri-O-benzyl-5a-carba-α-D-fucopyranosyl)-2-N-benzylaminooctadecane-1,3,4-triol 

Relevant academic research and scientific papers

RCAI-37, 56, 59, 60, 92, 101, and 102, cyclitol and carbasugar analogs of KRN7000: Their synthesis and bioactivity for mouse lymphocytes to produce Th1-biased cytokines

Cyclitol [RCAI-37 (1), 59 (5), 92 (7), and 102 (2)] and carbasugar analogs [RCAI-56 (3), 60 (4), and 101 (6)] of KRN7000 were synthesized through coupling reactions of the corresponding cyclitol or carbasugar derivatives with a cyclic sulfamidate (9) as t

NOVEL PSEUDOGLYCOLIPID AND USE THEREOF

The present invention provides a novel pseudoglycolipid effective for cancer treatment and the like and a novel synthesis intermediate therefor, as well as a medicament containing the novel pseudoglycolipid and the like. A compound represented by the foll